Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Use of α(2)-Agonists in Neuroanesthesia: An Overview.

Farag E, Argalious M, Sessler DI, Kurz A, Ebrahim ZY, Schubert A.

Ochsner J. 2011 Spring;11(1):57-69.

2.

The use of dexmedetomidine in anesthesia and intensive care: a review.

Farag E, Argalious M, Abd-Elsayed A, Ebrahim Z, Doyle DJ.

Curr Pharm Des. 2012;18(38):6257-65. Review.

PMID:
22762468
3.

Dexmedetomidine in the neurointensive care unit.

Farag E.

Discov Med. 2010 Jan;9(44):42-5. Review.

4.

Dexmedetomidine: current role in anesthesia and intensive care.

Afonso J, Reis F.

Rev Bras Anestesiol. 2012 Jan-Feb;62(1):118-33. doi: 10.1016/S0034-7094(12)70110-1. Review.

5.

Dexmedetomidine for neurological surgery.

Bekker A, Sturaitis MK.

Neurosurgery. 2005 Jul;57(1 Suppl):1-10; discussion 1-10. Review.

PMID:
15987564
6.

[Neuroprotection in neuroanesthesia: current practices in Germany].

Himmelseher S, Pfenninger E.

Anaesthesist. 2000 May;49(5):412-9. German.

PMID:
10883355
7.

Alpha-2 agonists for sedation of mechanically ventilated adults in intensive care units: a systematic review.

Cruickshank M, Henderson L, MacLennan G, Fraser C, Campbell M, Blackwood B, Gordon A, Brazzelli M.

Health Technol Assess. 2016 Mar;20(25):v-xx, 1-117. doi: 10.3310/hta20250. Review.

8.

Dexmedetomidine: perioperative applications in children.

Yuen VM.

Paediatr Anaesth. 2010 Mar;20(3):256-64. doi: 10.1111/j.1460-9592.2009.03207.x. Epub 2009 Dec 10.

PMID:
20015138
9.

[Alpha-2 adrenoreceptor agonists in anaesthesia and intensive care medicine].

Mavropoulos G, Minguet G, Brichant JF.

Rev Med Liege. 2014 Feb;69(2):97-101. Review. French.

PMID:
24683831
10.

[Dexmedetomidine in anesthesiology.].

Villela NR, Nascimento Júnior Pd.

Rev Bras Anestesiol. 2003 Feb;53(1):97-113. Portuguese.

11.

[Alpha 2-agonists in anesthesia and intensive medicine].

Bischoff P, Kochs E.

Anasthesiol Intensivmed Notfallmed Schmerzther. 1993 Feb;28(1):2-12. Review. German.

PMID:
8096770
12.

Influence of anesthesia on cerebral blood flow and cerebral metabolism: an overview.

Van Aken H, Van Hemelrijck J.

Agressologie. 1991;32(6-7):303-6.

PMID:
1843831
13.

Dexmedetomidine use in general anaesthesia.

Arcangeli A, D'Alò C, Gaspari R.

Curr Drug Targets. 2009 Aug;10(8):687-95.

PMID:
19702517
14.

Neuroanesthesia.

Jellish WS, Edelstein S.

Handb Clin Neurol. 2014;121:1623-33. doi: 10.1016/B978-0-7020-4088-7.00106-1. Review.

PMID:
24365438
15.

The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects.

Nelson LE, Lu J, Guo T, Saper CB, Franks NP, Maze M.

Anesthesiology. 2003 Feb;98(2):428-36.

PMID:
12552203
16.

Dexmedetomidine: a novel sedative-analgesic agent.

Gertler R, Brown HC, Mitchell DH, Silvius EN.

Proc (Bayl Univ Med Cent). 2001 Jan;14(1):13-21.

17.

Anesthesia for functional neurosurgery: the role of dexmedetomidine.

Rozet I.

Curr Opin Anaesthesiol. 2008 Oct;21(5):537-43. doi: 10.1097/ACO.0b013e32830edafd. Review.

PMID:
18784476
18.

Dexmedetomidine: a useful adjunct to consider in some high-risk situations.

Haselman MA.

AANA J. 2008 Oct;76(5):335-9. Review.

PMID:
18947160
19.

Neuroprotection by alpha 2-adrenergic agonists in cerebral ischemia.

Zhang Y, Kimelberg HK.

Curr Neuropharmacol. 2005 Oct;3(4):317-23.

20.

Role of signal transduction in anesthetic action. Alpha 2 adrenergic agonists.

Maze M, Regan JW.

Ann N Y Acad Sci. 1991;625:409-22. Review.

PMID:
1711813

Supplemental Content

Support Center